+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Left Atrial Appendage (LAA) Closure Devices Market

  • ID: 4855356
  • Report
  • May 2019
  • Region: Global
  • 93 pages
  • Energias Market Research
1 of 3

FEATURED COMPANIES

  • Abbott
  • Aegis Medical.
  • AtriCure, Inc.
  • Cardia, Inc.
  • Lifetech Scientific
  • SentreHEART, Inc.
  • MORE
The global left atrial appendage (LAA) closure devices market is anticipated to reach USD 958 Million by 2025, while augmenting at a significant CAGR of 19.8% during the forecast period. The growth in the market is attributed to the rising prevalence of atrial fibrillation and technological advancements in LAA closure devices. Moreover, rising adoption of minimally invasive therapies and growing aging population across the globe along with favorable government initiatives and increasing awareness for LAA devices to fuel the market demand over the forecast period.

Atrial fibrillation is associated with a fivefold increase in the risk of stroke as well as rising morbidity and mortality. Left atrial appendage closure devices are a promising site-direct therapy for stroke prevention in patients.

The years used for the assessment are as follows:
  • Historical year: 2015, 2016, 2017
  • Base year: 2018
  • Forecast period: 2019 - 2025
OBJECTIVES:
  • To classify the global left atrial appendage (LAA) closure devices market into segments and analyze their growth prospects individually
  • To analyze market trends, opportunities, drivers and restraints associated with the left atrial appendage (LAA) closure devices
  • Profiling key companies operating in the global left atrial appendage (LAA) closure devices market
  • To study market response with respect to the mergers and acquisitions in the industry
Note: Product cover images may vary from those shown
2 of 3

FEATURED COMPANIES

  • Abbott
  • Aegis Medical.
  • AtriCure, Inc.
  • Cardia, Inc.
  • Lifetech Scientific
  • SentreHEART, Inc.
  • MORE
CHAPTER 1. Market Scope and Methodology
1.1. Research Methodology
1.2. Research Scope & Assumptions
1.3. List of Data Sources

CHAPTER 2. Executive Summary
2.1. Global Left Atrial Appendage (LAA) Closure Devices- Market Snapshot

CHAPTER 3. Industry Analysis
3.1. Market Definition
3.2. Market Segmentation
3.3. Key Findings of the Global Left Atrial Appendage (LAA) Closure Devices Market
3.4. Market Opportunities
3.4.1. Technological advancements in LAA closure devices
3.5. Market Trends
3.5.1. Rising adoption of minimally invasive therapies
3.5.2. Increasing awareness for LAA devices
3.6. Market Driver Analysis
3.6.1. Growing aging population across the globe
3.6.2. Rising prevalence of atrial fibrillation
3.6.3. Favorable government initiatives
3.7. Market Restraint Analysis
3.7.1. High cost of devices

CHAPTER 4. Competitive Outlook
4.1. Company Share Analysis
4.2. Value Chain Analysis
4.3. Porters Five Forces Analysis

CHAPTER 5. Global Left Atrial Appendage (LAA) Closure Devices Market Size and Forecast (2015 – 2025)
5.1. Global Left Atrial Appendage (LAA) Closure Devices Market, By Product (USD Million)
5.1.1. Endocardial LAA Closure Devices
5.1.2. Epicardial LAA Closure Devices
5.2. Global Left Atrial Appendage (LAA) Closure Devices Market, By End-User (USD Million)
5.2.1. Ambulatory Surgical Centers
5.2.2. Hospitals
5.2.3. Others

CHAPTER 6. Global Left Atrial Appendage (LAA) Closure Devices Market, By Geography (2015 – 2025)
6.1. North America Left Atrial Appendage (LAA) Closure Devices Market
6.1.1. North America Left Atrial Appendage (LAA) Closure Devices Market, By Product (USD Million)
6.1.2. North America Left Atrial Appendage (LAA) Closure Devices Market, By End-User (USD Million)
6.1.3. North America Left Atrial Appendage (LAA) Closure Devices Market, By Country
6.1.3.1. United States
6.1.3.2. Canada
6.1.3.3. Mexico
6.2. Europe Left Atrial Appendage (LAA) Closure Devices Market
6.2.1. Europe Left Atrial Appendage (LAA) Closure Devices Market, By Product (USD Million)
6.2.2. Europe Left Atrial Appendage (LAA) Closure Devices Market, By End-User (USD Million)
6.2.3. Europe Left Atrial Appendage (LAA) Closure Devices Market, By Country
6.2.3.1. France
6.2.3.2. United Kingdom
6.2.3.3. Spain
6.2.3.4. Russia
6.2.3.5. Germany
6.2.3.6. Italy
6.2.3.7. Rest of Europe
6.3. Asia-Pacific Left Atrial Appendage (LAA) Closure Devices Market
6.3.1. Asia-Pacific Left Atrial Appendage (LAA) Closure Devices Market, By Product (USD Million)
6.3.2. Asia-Pacific Left Atrial Appendage (LAA) Closure Devices Market, By End-User (USD Million)
6.3.3. Asia-Pacific Left Atrial Appendage (LAA) Closure Devices Market, By Country
6.3.3.1. China
6.3.3.2. India
6.3.3.3. Japan
6.3.3.4. Rest of Asia-Pacific
6.4. Central & South America Left Atrial Appendage (LAA) Closure Devices Market
6.4.1. Central & South America Left Atrial Appendage (LAA) Closure Devices Market, By Product (USD Million)
6.4.2. Central & South America Left Atrial Appendage (LAA) Closure Devices Market, By End-User (USD Million)
6.4.3. Central & South America Left Atrial Appendage (LAA) Closure Devices Market, By Country
6.4.3.1. Argentina
6.4.3.2. Brazil
6.4.3.3. Rest of Central & South America
6.5. Middle East and Africa Left Atrial Appendage (LAA) Closure Devices Market
6.5.1. Middle East and Africa Left Atrial Appendage (LAA) Closure Devices Market, By Product (USD Million)
6.5.2. Middle East and Africa Left Atrial Appendage (LAA) Closure Devices Market, By End-User (USD Million)
6.5.3. Middle East and Africa Left Atrial Appendage (LAA) Closure Devices Market, By Country
6.5.3.1. Saudi Arabia
6.5.3.2. South Africa
6.5.3.3. Rest of Middle East and Africa

CHAPTER 7. Key Players and Strategic Developments
7.1. Abbott
7.1.1. Business Overview
7.1.2. Product and Service Offering
7.1.3. Financial Overview
7.1.4. Strategic Developments
7.2. AtriCure, Inc.
7.2.1. Business Overview
7.2.2. Product and Service Offering
7.2.3. Financial Overview
7.2.4. Strategic Developments
7.3. Boston Scientific Corporation
7.3.1. Business Overview
7.3.2. Product and Service Offering
7.3.3. Financial Overview
7.3.4. Strategic Developments
7.4. Lifetech Scientific
7.4.1. Business Overview
7.4.2. Product and Service Offering
7.4.3. Financial Overview
7.4.4. Strategic Developments
7.5. SentreHEART, Inc.
7.5.1. Business Overview
7.5.2. Product and Service Offering
7.5.3. Financial Overview
7.5.4. Strategic Developments
7.6. Cardia, Inc.
7.6.1. Business Overview
7.6.2. Product and Service Offering
7.6.3. Financial Overview
7.6.4. Strategic Developments
7.7. Occlutech International AB
7.7.1. Business Overview
7.7.2. Product and Service Offering
7.7.3. Financial Overview
7.7.4. Strategic Developments
7.8. Lepu Medical Technology (Beijing) Co., Ltd.
7.8.1. Business Overview
7.8.2. Product and Service Offering
7.8.3. Financial Overview
7.8.4. Strategic Developments
7.9. Aegis Medical.
7.9.1. Business Overview
7.9.2. Product and Service Offering
7.9.3. Financial Overview
7.9.4. Strategic Developments
Note: Product cover images may vary from those shown
3 of 3
  • Abbott
  • AtriCure, Inc.
  • Boston Scientific Corporation
  • Lifetech Scientific
  • SentreHEART, Inc.
  • Cardia, Inc.
  • Occlutech International AB
  • Lepu Medical Technology (Beijing) Co., Ltd.
  • Aegis Medical.
Note: Product cover images may vary from those shown
Adroll
adroll